Lack of efficacy of apremilast in 9 patients with severe alopecia areata

J Am Acad Dermatol. 2017 Oct;77(4):773-774. doi: 10.1016/j.jaad.2017.05.034.

Authors

Lucy Y Liu¹, Brett A King²

Affiliations

¹ Yale University School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Yale University, New Haven, Connecticut. Electronic address: brett.king@yale.edu.

PMID: 28917463
DOI: 10.1016/j.jaad.2017.05.034

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Age Factors
Aged
Alopecia Areata / diagnosis*
Alopecia Areata / drug therapy*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Needs Assessment
Retrospective Studies
Risk Assessment
Sampling Studies
Severity of Illness Index
Sex Factors
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use
Treatment Failure
Young Adult

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast